阿尔蒂维昂

最新新闻

• 评级变动
  Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• 评级变动
  Lake Street Initiates Artivion(AORT.US) With Buy Rating, Announces Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/4/8
• 评级变动
  Ladenburg Thalmann Upgrades Artivion(AORT.US) to Buy Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/4/10
• 评级变动
  Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $58
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 公司公告
  GraniteShares YieldBOOST CRCL ETF: CryoLife, Inc. - Name/Symbol Change Option Symbol: CRY New Symbol: AORT
  OCC · 2022/1/20
• 评级变动
  CCORF Maintains Artivion(AORT.US) With Buy Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/2/13
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/7/20
• 评级变动
  Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $41 to $58
  \u5e02\u573a\u8d44\u8baf · 2026/2/14
• Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $38 to $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $39
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/4/7
• Earnings Flash (AORT) Artivion, Inc. Posts Q2 Adjusted EPS $0.13 per Share, Vs. FactSet Est of $0.10
  MT Newswires · 2026/8/7
• 评级变动
  CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/3/9
• 评级变动
  A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/9
• 评级变动
  Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)
  TipRanks · 2026/4/7
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Atai Beckley N.V. (ATAI) and Artivion (AORT)
  TipRanks · 2026/3/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。